Universe Pharmaceuticals INC (NASDAQ:UPC – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 75,844 shares, an increase of 154.7% from the August 31st total of 29,772 shares. Currently, 3.5% of the company’s shares are sold short. Based on an average daily volume of 604,499 shares, the days-to-cover ratio is presently 0.1 days.
Analyst Ratings Changes
Several research analysts recently commented on the stock. Weiss Ratings raised shares of Universe Pharmaceuticals from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 29th. Wall Street Zen raised shares of Universe Pharmaceuticals to a “hold” rating in a research report on Saturday, August 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Universe Pharmaceuticals has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on UPC
Universe Pharmaceuticals Stock Performance
Universe Pharmaceuticals (NASDAQ:UPC – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported ($1.38) earnings per share for the quarter. The firm had revenue of $4.52 million for the quarter.
About Universe Pharmaceuticals
Universe Pharmaceuticals Inc (NASDAQ: UPC) is a China-based pharmaceutical and healthcare products company. The company develops, manufactures and markets pharmaceutical products, health supplements and medical devices, with an emphasis on traditional Chinese medicine and other products used in everyday healthcare.
Its product portfolio includes over-the-counter and prescription medicines designed to address a range of conditions, including respiratory, cardiovascular, digestive and dermatological ailments.
See Also
- Five stocks we like better than Universe Pharmaceuticals
- CAVA Stock Slips: Sector Fear or Valuation Reality?
- Why Equal-Weight Funds Hide A Yield Curve Catch
- 5 Scary-Good Stocks With Strong October Catalysts and Breakout Potential
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
